HRTX
Heron Therapeuti
0.3476$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.3% | 40.1% | 28.5% | 31.4% | 18.2% | 10.0% | 7.7% | 227.5% | 265.3% | 250.0% | 7.3% | 3,179.6% | 3,135.8% | 238.9% | 248.7% | 27.7% | – | – | – | – | 2.7% | 14.9% | 35.5% | 42.2% | 40.8% | 53.3% | 51.0% | 51.2% | 26.8% | 26.7% | |
| 49.7% | 59.9% | 71.5% | 68.6% | 81.8% | 90.0% | 92.3% | 100.0% | 100.0% | 100.0% | 92.7% | 100.0% | 100.0% | 100.0% | 100.0% | 72.3% | – | – | – | – | 97.3% | 85.1% | 64.5% | 57.8% | 59.2% | 46.7% | 49.0% | 48.8% | 73.2% | 73.3% | |
| 18.7% | 21.5% | 22.0% | 21.1% | 110.3% | 167.5% | 115.2% | 178.6% | 212.7% | 191.0% | 282.6% | 4,700.0% | 5,286.4% | 618.2% | 558.3% | 1,270.4% | – | – | – | – | 8,062.9% | 450.4% | 180.7% | 114.7% | 196.9% | 151.5% | 99.8% | 30.8% | 11.6% | 8.0% | |
| 61.0% | 43.0% | 30.0% | 31.9% | 102.9% | 75.3% | 60.1% | 57.8% | 59.7% | 66.1% | 67.3% | 1,136.2% | 1,167.2% | 294.0% | 305.2% | 542.0% | – | – | – | – | 1,670.5% | 83.1% | 37.8% | 26.0% | 47.6% | 46.5% | 34.8% | 46.0% | 37.0% | 35.3% | |
| 87.2% | 71.5% | 59.0% | 55.4% | 209.7% | 231.5% | 175.3% | 236.4% | 272.4% | 257.2% | 342.6% | 5,836.2% | 6,453.7% | 884.0% | 863.6% | 1,812.4% | – | – | – | – | 13,460.4% | 717.4% | 301.9% | 202.1% | 316.6% | 299.0% | 211.2% | 135.8% | 81.2% | 74.9% | |
| -45.5% | -6.4% | 12.5% | -8.3% | -128.0% | -167.1% | -86.9% | -136.4% | -172.4% | -157.2% | -349.9% | -5,736.2% | -6,353.7% | -812.2% | -763.6% | -1,712.4% | – | – | – | – | -13,363.2% | -632.4% | -237.4% | -144.3% | -257.4% | -252.3% | -162.2% | -87.1% | -8.0% | -1.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 57.7% | – | – | – | – | 208.3% | 12.8% | 3.4% | 1.0% | 2.1% | 2.8% | 2.3% | 3.0% | 4.2% | 6.2% | |
| -43.3% | – | 13.5% | – | -127.2% | -150.8% | -81.8% | -133.2% | -172.0% | -151.8% | 102.3% | -4,805.8% | -6,266.9% | -810.3% | -553.1% | -1,770.1% | – | – | – | – | -13,537.4% | -641.9% | -230.8% | -140.3% | -256.4% | -255.6% | -169.1% | -87.0% | -9.4% | -13.0% | |
| 12.8% | 4.1% | 3.0% | 1.5% | -382.0% | -95.5% | -18.0% | -46.4% | -1.8% | -4.9% | 2.2% | 10.0% | -86.7% | -9.7% | -198.9% | 58.7% | – | – | – | – | -85.9% | 12.7% | 10.0% | 1.3% | -3.2% | -3.5% | -44.1% | 2.1% | – | – | |
| -50.3% | -10.5% | -13.5% | -10.3% | 254.1% | -57.3% | -65.0% | -90.0% | -170.6% | -152.3% | 97.7% | -4,893.9% | -6,266.9% | -795.2% | -564.6% | -1,828.8% | – | – | – | – | -13,537.4% | -641.9% | -230.8% | -140.3% | -253.2% | -252.1% | -124.9% | -87.0% | -9.4% | -13.0% | |
| -38.0% | -4.7% | -10.0% | -7.4% | -119.8% | -154.3% | -78.8% | -122.9% | -160.7% | -148.9% | 109.6% | -5,666.0% | -6,242.0% | -784.0% | -535.5% | -1,684.7% | – | – | – | – | -13,277.2% | -624.1% | -235.5% | -137.9% | -254.2% | -248.8% | -159.5% | -81.7% | -3.5% | -11.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.